HANNAH TRIA: Open Payments
NPI 1891206280 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 16 payments from 9 companies in 2025. Trend: 2023 $118 · 2024 $109 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $97 |
| ABBVIE INC. | 4 | $75 |
| TOLMAR, INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: Wegovy, VRAYLAR, Ozempic, JATENZO, QULIPTA, AIRSUPRA, JARDIANCE, VAXELIS.
Industry payments across NC — which companies pay providers there.
